The pathology of pulmonary artery hypertension

Clinics in Chest Medicine

Volumn 22, Issue 3, 2001, Pages 393-404

  Meyrick, Barbara ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOPATHOLOGY; HUMAN; LUNG ARTERY PRESSURE; LUNG STRUCTURE; MICROSCOPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0034815525     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70279-3     Document Type: Article

References (57)

1. Primary and thromboembolic pulmonary hypertension: A quantitative pathologic study
2. Endothelin-1 (ET-1) receptor populations and gene expression are altered in chronic pulmonary hypertension (CPH) induced by continuous air embolization (CAE)
3. Primary pulmonary hypertension: A histopathologic study of 80 cases
4. Bosentan, a dual endothelin receptor antagonist, improves exercise capacity and hemodynamics in patients with pulmonary arterial hypertension: Results of a double blind, randomized, placebo-controlled trial
5. Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension
6. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
7. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats
8. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
9. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels
10. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection
11. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: Potential contribution of specific protein kinase c isoenzymes
12. Hypoxic remodeling of the rat pulmonary arterial microcirculation assessed by microdissection
13. The structure of the wall of the rat intraacinar pulmonary artery: An electron microscopic study of microdissected preparations
14. Familial pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
15. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat
16. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities
17. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling
18. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
19. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
20. An overview of epithelio-mesenchymal transformation
21. The pathology of hypertensive pulmonary vascular disease
22. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension
23. Ultrastructural analysis of contractile cell development in lung microvessels in hyperoxic pulmonary hypertension. Fibroblasts and intermediate cells selectively reorganize nonmuscular segments
24. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension
25. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study
26. Ultrastructural features of the distended pulmonary arteries of the normal rat
27. Hypoxia-induced structural changes in the media and adventitia of rat hilar pulmonary artery, and their regression
28. Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. A quantitative ultrastructural study
29. 3H]-thymidine by cells of rat pulmonary arteries and alveolar wall
30. Pulmonary hypertension. Anatomic and physiologic correlates
31. Development of Crotalaria pulmonary hypertension: Hemodynamic and structural study
32. Smooth muscle myosin in precursor and mature smooth muscle cells in normal pulmonary arteries and the effect of hypoxia
33. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension
34. Insulin-like growth factor and pulmonary hypertension induced by continuous air embolization in sheep
35. Continuous air embolization into sheep causes sustained pulmonary hypertension and increased pulmonary vasoreactivity
36. Granulocyte depletion attenuates sustained pulmonary hypertension and increased pulmonary vasoreactivity caused by continuous air embolization in sheep
37. Sequence of structural changes and elastin peptide release during vascular remodeling in sheep with chronic pulmonary hypertension induced by air embolization
38. Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension
39. Expression of transforming growth factor-β mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension
40. Histopathology of primary pulmonary hypertension: A qualitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute primary pulmonary hypertension registry
41. Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features
42. Lung biopsy in congenital heart disease: A morphometric approach to pulmonary vascular disease
43. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects
44. The pulmonary circulation: Remodeling in growth and disease. The 1978 J. Burns Amberson lecture
45. Changes in arteriole in acute and chronic hypoxic pulmonary hypertension and recovery in rat
46. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
47. Cell-specific differences in ET-1 system in adjacent layers of main pulmonary artery. A new source of ET-1
48. Regional variability in preproendothelin-1 gene expression in sheep pulmonary artery and during the onset of air-induced chronic pulmonary hypertension: Participation of arterial smooth muscle cells
49. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, causes familial primary pulmonary hypertension
50. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family
51. Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility
52. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
53. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
54. Smooth muscle cells and fibroblasts of the coronary arteries derive from epithelialmesenchymal transformation of the epicardium
55. Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases
56. Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension
57. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension